BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:20251102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Central Standard Time TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Central Daylight Time TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Please join United Therapeutics and the Pulmonary Fibrosis Foun dation (PFF) for an Industry Hosted Webinar at noon CT on Tuesday\, Octobe r 31. This presentation will provide an overview of pulmonary hypertension associated with interstitial lung disease (PH-ILD). In this webinar\, our speakers will define PH-ILD\, discuss how ILD progresses to PH-ILD\, and review symptoms of PH-ILD that patients may experience. We invite patients \, caregivers\, and family members to join the webinar. Register NowPresen ted by:Dr. Hyun Kim – Director of the Interstitial Lung Disease program an d Associate Professor of Medicine at the University of Minnesota Medical S choolDr. Thenappan Thenappan – Associate Professor of Medicine\, Cardiolog y at the University of Minnesota Medical School Moderated by:Dr. Amy Hajar i-Case – Senior Medical Advisor of Education and Awareness at the PFF and Director of the Interstitial Lung Disease Program and Pulmonary and Critic al Care Research Department at Piedmont HealthcareThis Industry Hosted Web inar is supported by United Therapeutics. Opinions expressed and resources shared may not have been reviewed by the PFF before distribution through PFF channels\, or reflect official positions of the PFF unless it is expli citly noted as a result of official PFF approval. References to specific c ommercial entities (companies) or products do not reflect review or endors ement by the PFF unless it is explicitly noted as a result of official PFF approval. DTEND:20231031T180000Z DTSTAMP:20260421T124547Z DTSTART:20231031T170000Z LOCATION: SEQUENCE:0 SUMMARY:What Is Pulmonary Hypertension Associated with Interstitial Lung Di sease (PH-ILD) and How Is It Diagnosed? | Industry Hosted Webinar UID:RFCALITEM639123543473530457 X-ALT-DESC;FMTTYPE=text/html:

Please join United Therapeutics and the Pul monary Fibrosis Foundation (PFF) for an Industry Hosted Webinar at noon CT on Tuesday\, October 31. This presentation will provide an overview of pulmonary hypertension associated with interstitial lung di sease (PH-ILD). In this webinar\, our speakers will define PH-ILD\, discus s how ILD progresses to PH-ILD\, and review symptoms of PH-ILD that patien ts may experience. We invite patients\, caregivers\, and family members to join the webinar.

Presented by:

Hy
unKim_VAM_2022_1

Dr. Hyun Kim – Director of the Interstitial Lung Disease program and Associate Professor of Medicine at the University of M innesota Medical School

Dr. Thenappan Thenappan – Ass ociate Professor of Medicine\, Cardiology at the University of Minnesota M edical School

Moderated by:

Dr. Amy Hajari-Case – Senior Medical Advisor of Education and Awareness at the PFF and Director of the Interstitial Lung Disease Program and Pulmonary and Critical Care Research Department at Piedmont Healthcare

This Industry Hosted Webinar is supported by United Therapeutics. Opinions expressed and resour ces shared may not have been reviewed by the PFF before distribution throu gh PFF channels\, or reflect official positions of the PFF unless it is ex plicitly noted as a result of official PFF approval. References to specifi c commercial entities (companies) or products do not reflect review or end orsement by the PFF unless it is explicitly noted as a result of official PFF approval.

END:VEVENT END:VCALENDAR